Related references
Note: Only part of the references are listed.Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2
Oliver Koeberling et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Challenges and progress in the development of a serogroup B meningococcal vaccine
Susan Lewis et al.
EXPERT REVIEW OF VACCINES (2009)
Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF VACCINES (2009)
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
Caroline L. Trotter et al.
EXPERT REVIEW OF VACCINES (2009)
Quality-control issues and approaches in vaccine development
Bernard Metz et al.
EXPERT REVIEW OF VACCINES (2009)
Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385 A road map for discovering new antigens
Jeovanis Gil et al.
HUMAN VACCINES (2009)
Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates
Jeannette N. Williams et al.
INFECTION AND IMMUNITY (2009)
Towards the Immunoproteome of Neisseria meningitidis
Tom A. Mendum et al.
PLOS ONE (2009)
Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution
F. Marc LaForce et al.
VACCINE (2009)
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
Johan Holst et al.
VACCINE (2009)
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
Che-Hung Lee et al.
VACCINE (2009)
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
Susanne Jacobsson et al.
VACCINE (2009)
Meningococcal C conjugate vaccine: The experience in England and Wales
Helen Campbell et al.
VACCINE (2009)
Preparation of bacterial polysaccharide-protein conjugates: Analytical and manufacturing challenges
Carl E. Frasch
VACCINE (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Meningococcal B vaccine development and evaluation of efficacy
Loek van Alphen et al.
HUMAN VACCINES (2008)
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles
Michelle Finney et al.
HUMAN VACCINES (2008)
Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines
Joanne E. Russell et al.
MICROBIOLOGY-SGM (2008)
Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases
Angela Bardotti et al.
VACCINE (2008)
Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry
Tracie L. Williams et al.
VACCINE (2008)
Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide
Seshu K. Gudlavalleti et al.
VACCINE (2007)
Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid
I. A. F. B. Silveira et al.
VACCINE (2007)
Meningococcal vaccine in travelers
Annelies Wilder-Smith
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant
Jeannette N. Williams et al.
INFECTION AND IMMUNITY (2007)
Exploring the proteome of meningococcal outer membrane vesicle vaccines
Jun X. Wheeler et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens
Thomas E. Vaughan et al.
VACCINE (2006)
Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier
AE Pérez et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy
SK Gudlavalleti et al.
CARBOHYDRATE RESEARCH (2006)
Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant:: Proteomic and immunological comparison with detergent-derived outer membrane vesicles
G Ferrari et al.
PROTEOMICS (2006)
Outer membrane vesicles of the VA-MENGOC-BC (R) vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry
Liliam Uli et al.
PROTEOMICS (2006)
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254
C Vipond et al.
PROTEOMICS (2006)
Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B
DMB Post et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870
VC Hou et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58
G Mignogna et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Determination of meningococcal polysaccharides by capillary zone electrophoresis
DH Lamb et al.
ANALYTICAL BIOCHEMISTRY (2005)
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135
A Bardotti et al.
VACCINE (2005)
Characterization of the Protein Content of a Meningococcal Outer Membrane Vesicle Vaccine by Polyacrylamide Gel Electrophoresis and Mass Spectrometry
Caroline Vipond et al.
HUMAN VACCINES (2005)
Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB
QW Xu et al.
ANALYTICAL BIOCHEMISTRY (2005)
Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD)
G Kao et al.
VACCINE (2004)
Quantification of residual EDU (N-ethyl-N′-(dimethylaminopropyl) carbodiimide (EDC) hydrolyzed urea derivative) and other residual by LC-MS/MS
QP Lei et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
LC/MS characterization of meningococcal depolymerized polysaccharide group C reducing endgroup and internal repeating unit
XX Cai et al.
ANALYTICAL CHEMISTRY (2004)
Determination of lipid profile in meningococcal polysaccharide reversed-phase liquid chromatography
Y Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Simple and rapid technique for monitoring the quality of meningococcal polysaccharides by high performance size-exclusion chromatography
C von Hunolstein et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2003)
Evaluation of meningococcal C oligosaccharide conjugate vaccines by size-exclusion chromatography/multi-angle laser light scattering
K Jumel et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2002)
Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture
C Jones et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines
MM Ho et al.
VACCINE (2002)
Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine
O Perez et al.
INFECTION AND IMMUNITY (2001)
Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection
S Ricci et al.
VACCINE (2001)
Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines
MM Ho et al.
VACCINE (2000)
Determination of free carrier protein in protein-polysaccharide conjugate vaccines by micellar electrokinetic chromatography
DH Lamb et al.
JOURNAL OF CHROMATOGRAPHY A (2000)
Share Paper
